Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
May 08, 2026
TickeronGET DAILY SIGNALS
XLV in a Short-Term Downtrend: Key Levels and Signals for Health Care ETF Traders

XLV in a Short-Term Downtrend: Key Levels and Signals for Health Care ETF Traders

Key Takeaways

  • XLV is in a short-term downtrend with a strong sell technical rating from moving averages and oscillators.
  • Price is consolidating near recent lows around 144-145, below key moving averages including the 20-day at 145.94 and 200-day at 147.23.
  • RSI(14) at approximately 46 indicates neutral momentum, neither overbought nor oversold.
  • MACD shows a sell signal, reflecting weakening momentum.
  • Key support zones at 144.04-144.43 and lower at 125-130; resistance at 145.06-145.69 and 137.5.
  • Volume has been average, with no significant spikes noted recently.

Understanding the Current Trend

The Health Care Select Sector SPDR Fund (XLV) has moved into a short-term downtrend after reaching a peak near 160 earlier this year. In my view, the price action over the last 30 days reflects a decline of about 0.60%, with a steeper 5.74% drop over the past quarter. Recently, the ETF tested lows around 142 before pulling back slightly to current levels near 144-145. This comes after a breakdown from higher levels, leaving price below multiple short-term moving averages. While the longer-term structure holds some constructive elements following a break of a descending trendline earlier, the recent weakness has me watching closely for signs of continuation or a potential reversal.

Critical Support and Resistance Zones

From what I see, traders are honing in on nearby pivot levels based on recent price action. Classical pivots indicate immediate support at S1 144.43, S2 144.04, and S3 143.80, with resistance at R1 145.06, R2 145.30, and R3 145.69. On a broader chart, stronger support lies in the 125-130 zone, where institutional absorption has occurred, and resistance clusters near 137.5-138, with an unfilled gap around 140 that could draw price higher on any upside move. Holding above 144 might help stabilize things, but a breach below could lead to deeper tests.

Moving Averages Pointing Lower

The moving averages largely signal sell, with 11 out of 12 showing bearish readings. The 5-day MA is at 144.56 (simple), the 20-day ranges from 145.13-145.94, the 50-day from 144.86-148.34, and the 200-day at 146.24-147.23. With price trading below these levels, the downtrend is confirmed, though the closeness to shorter MAs hints at possible consolidation. I think a crossover above the 20-day would mark the first bullish shift worth noting.

Momentum Indicators in Bearish Territory

RSI(14) is holding in neutral territory around 44-46 across sources, steering clear of oversold levels below 30. The MACD(12,26) at -0.06 with a sell signal highlights bearish divergence. Stochastic indicators also tilt toward sell, with STOCH(9,6) at 21.45 and Williams %R at -74 signaling downward pressure. Overall, the oscillators align with a strong sell rating, consistent with the technical summary.

Volume Trends and Market Activity

Recent daily volume has averaged 8-12 million shares, with the latest session at 7.4 million and no unusual spikes. Volume has tracked the price decline without picking up speed, which points to orderly selling rather than panic. The 20-day average volume sits around 8.4 million, reflecting steady activity in this defensive sector ETF. One thing that stands out is how this controlled volume supports the current consolidation.

Leveraging Tickeron’s AI Daily Buy/Sell Signals

In my analysis, I’ve found Tickeron’s AI Daily Buy/Sell Signals particularly useful for digging deeper into XLV. These signals use artificial intelligence to analyze vast datasets, including technical indicators, price patterns, and historical trends. They help spot potential buy or sell opportunities by identifying recurring market behaviors, momentum shifts, and anomalies that might escape traditional methods. I rely on them to refine entry and exit points, confirm trend strength, and make better decisions in choppy markets. Updated daily, they add an objective edge to my chart work—worth checking out if you’re building AI-driven insights into your own strategy.

Technical Outlook and Levels to Monitor

This is important because market participants are focused on potential stabilization near 144 support, where a break above 145.30 resistance could bring short-term relief. Deeper support at 125-130 might draw buyers if tested, though failure there could expose the 127.35 52-week low. I’m watching RSI for any oversold bounces and MACD for histogram changes. Clearing the 137.5-140 gap on the upside would aim for prior highs, but trades sustained below 144 suggest further downside. Volatility is moderate, so volume confirmation around these levels will be key.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: XLV

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


XLV in -2.17% downward trend, falling for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where XLV declined for three days, in 250 of 308 cases, the price declined further within the following month. The odds of a continued downward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for XLV moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 27 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XLV as a result. In 72 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for XLV turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 38 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.

Following a +0.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 264 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

XLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 225 of 273 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Market Cap

The average market capitalization across the State Street Health Care Select Sector SPDR ETF (XLV) ETF is 115.33B. The market cap for tickers in the group ranges from 9.59B to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is HSIC at 9.59B.

High and low price notable news

The average weekly price growth across all stocks in the State Street Health Care Select Sector SPDR ETF (XLV) ETF was -6%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was 19%. SYK experienced the highest price growth at 0%, while UNH experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the State Street Health Care Select Sector SPDR ETF (XLV) ETF was 61%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was 26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 46
Price Growth Rating: 35
SMR Rating: 59
Profit Risk Rating: 70
Seasonality Score: 33 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
SSO is a 2x daily leveraged ETF (exchange-traded fund) that seeks double the daily return of the S&P 500, while XXX is a non-leveraged, passive fund blending roughly 75% S&P 500 exposure with 25% XRP, a major cryptocurrency. Both funds charge comparable fees — about 0.87% for SSO and roughly 0.85% for XXX — but their risk profiles are fundamentally different.
Alphabet Inc. (GOOG) , the parent of Google, YouTube, and Google Cloud, is a common stock, not an exchange-traded fund. The central target of $400 is the arithmetic mean of current analyst price targets, which span a wide band from roughly $300 to $500, with the broad average near $397.
AAPL has shown stronger relative performance in recent weeks, holding near record highs while many artificial intelligence (AI)-focused tech stocks sold off. MSFT has lagged the market and now trades below its 50-day moving average amid concerns over heavy AI infrastructure spending.
Bending Spoons reported third-quarter 2026 revenue of $780.22 million, up 125.1% year over year and above the roughly $745.86 million consensus estimate. Earnings per share (EPS) came in at $0.42, beating the $0.26 consensus estimate by $0.16.
GOOG declined roughly 20% over the past 30 days, falling from about $331 to around $264 per share. The sell-off was triggered by Alphabet's third-quarter 2026 report, which revealed slowing Search advertising growth and an earnings miss.